Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

TTP Labtech Supports Dart NeuroScience in the Study of Memory Disorders

Published: Friday, June 14, 2013
Last Updated: Friday, June 14, 2013
Bookmark and Share
TTP Labtech’s comPOUND® & comPILER® deliver scalable, secure compound storage and tube-to-plate processing.

TTP Labtech has signed an agreement with Dart NeuroScience, LLC (DNS), a specialized pharmaceutical company, to supply its modular compound storage and retrieval systems, comPOUND® and comPILER®.

The platform will enable the safe, long-term storage of the newly formed and rapidly expanding DNS small molecule compound libraries, supporting the company’s quest to discover innovative drugs and targeted therapies for life-long cognitive vitality and the treatment of memory disorders.

Through strong investment in its internal and external programs, DNS is driving new scientific discovery with some of the leading experts in this field.

Its unique approach originated from scientific findings at the Cold Spring Harbor Laboratory that identified the genes controlling fruit fly memory.

By extending the functional links of these genes to the memory of mammals, DNS has been able to apply new and advanced methodologies to identify small molecular drugs from mammalian targets.

The group is screening newly discovered gene targets involved with memory formation against small molecule compounds in order to identify those that enhance or inhibit their biochemical activity.

This is allowing DNS to fill its pipeline with exciting drug candidates for new targeted therapies and memory enhancers.

By utilizing its integrated teams of structural biologists, medicinal chemists, production and purification specialists, the organization aims to apply its target-based molecule design to create and store up to 100,000 compounds a year.

“We are delighted to announce TTP Labtech as the chosen supplier of our compound management solution. We are investing heavily in our IP portfolio and developing our own proprietary compounds in-house. As such, identifying a secure solution that will ensure compound integrity and guarantee the protection of this investment has been paramount,” commented Jose Quiroz, Manager of Laboratory Systems at Dart NeuroScience.

With a small footprint, fast automated operation and a flexible, modular design, comPOUND will prove a sturdy investment for the DNS team. “We know that TTP Labtech’s comPOUND-comPILER platform will provide the exceptional long-term storage and tube-to-plate processing capabilities that we require,” Quiroz said.

Scalability and future proofing was also a key factor for the group at DNS. “We are starting with three comPOUNDs and one comPILER system, but with the scope to integrate up to ten comPOUND stores simultaneously with our comPILER platform, we can sensibly amortize our investment. This is something that is not possible with a big integrated store requiring a significant capital outlay. Instead, we can effectively grow our library and our storage facilities in parallel - this is very appealing to us.”

James Craven, Product Manager for sample storage at TTP Labtech, described the new agreement as “collaborative” and a great example of the unique approach that the company brings to its sales process.

“We’ve worked closely with the screening and compound management teams at DNS for a number of years, supplying other products such as our mosquito and acumen, and were keen to help them find a future-proofed compound management system,” he said. “By working very closely alongside the DNS team, we could propose a comPOUND-comPILER set-up coupled with our pneumatic tube transport system, lab2lab, with everything working seamlessly together to meet their unique requirements and objectives.”

Craven continued: “We have customers with comPOUNDs that have been in place for over ten years. The plug-and-play storage units have been relocated across facilities and reinstalled on new continents as the global screening needs of the company have evolved. This makes for a sensible investment, and we tend to find that our systems are never left redundant. Our robust technology offers innovative operation and long term sample viability, making comPOUND a smart long-term investment.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

David Newble Joins TTP Labtech as New Managing Director
Recent appointment promises to drive innovation strategy and further strengthen R&D pipeline
Thursday, June 18, 2015
TTP Labtech and Almac Group’s Form Strategic Alliance
Alliance consolidates fluorescence lifetime technology to form a one-stop shop for compound screening.
Thursday, February 05, 2015
Innovative Technology Enables First Crystal Structure of mGlu5 Transmembrane Domain to be Determined
Several novel drug candidates have been identified to help treat specific neuropsychiatric disorders.
Saturday, July 19, 2014
TTP Labtech Revenues up 43%
The company has reported an impressive 43% increase in revenues and an associated increase in profits over 2013.
Monday, June 23, 2014
TTP Labtech Acquires Assets from AssayMetrics
Significant improvements in assay reagents and availability of HTS-compatible readers has propelled fluorescence lifetime technology to the vanguard of cost-effective screening technologies.
Thursday, January 09, 2014
Major Protein Structure Discovery Achieved Using TTP Labtech’s Mosquito LCP
Researchers have successfully reported the structure of a Class B G-Protein Coupled Receptor (GPCR) using lipidic cubic phase (LCP) protein crystallisation.
Friday, July 26, 2013
TTP Labtech Announces On-Going Growth
An investment of £3.8M in global R&D sees product sales grow over 20%.
Thursday, July 11, 2013
TTP Labtech will Showcase its Latest Automated Technology Innovations in Europe
Delivering a wealth of new products to the attendees of ELA 2012.
Monday, May 21, 2012
TTP Labtech Announces Company Growth
New product offering demonstrates strong commitment to product development.
Friday, May 11, 2012
TTP LabTech Presents Protein Crystallography Community with News Service
TTP LabTech has launched the 2011 issue of its LabCrystal magazine, designed specifically for scientists who perform protein crystallography.
Monday, December 19, 2011
Webinar Places Spotlight on Mosquito Applications
Leading speakers discuss hot topics for TTP LabTech’s mosquito Crystal and mosquito LCP.
Tuesday, September 13, 2011
The Rapid Screening and Optimisation of Crystallisation Conditions of the Bacterial Periplasmic Binding Protein, HbpA and the Elucidation of its Role as a Glutathione Import Protein
A recent study reported in PNAS employed TTP LabTech’s mosquito® crystal for the identification of a bacterial periplasmic lipoprotein in H. influenzae Rd.
Monday, September 12, 2011
Driving the Science of the Future
TTP LabTech announce that they are founding sponsors of the inaugural European Lab Automation (ELA) conference and exhibition, to be held at the Conference Centre Hamburg (CCH), Hamburg, Germany, from the 30th June-1st July.
Friday, May 20, 2011
TTP LabTech to Demonstrate New mosquito® LCP at ACA, Chicago
Dedicated solution to increase throughput of lipid cubic phase screening
Wednesday, July 07, 2010
Increased Demand Drives Queensland Compound Library Expansion
QCL capacity is increased by the acquisition of a fourth additional comPOUND® storage module.
Thursday, June 10, 2010
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!